Open-Label, Randomized, Comparative, Multi-Center Clinical Trial on the Therapeutic Effect of Tacrolimus (Prograf Cap.) in Combination With Low-Dose Corticosteroid Compared With High-Dose Corticosteroid Alone in Patients With Minimal-Change Nephrotic Syndrome (MCNS)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 Apr 2017
At a glance
- Drugs Tacrolimus (Primary) ; Prednisolone
- Indications Nephrotic syndrome
- Focus Therapeutic Use
- Acronyms T-OPTIMUM
- Sponsors Astellas Pharma
- 24 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 12 Jan 2017 Planned End Date changed from 1 Oct 2016 to 1 Sep 2017.
- 12 Jan 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Sep 2017.